Uppsala, Sweden

Vladimir Tolmachev

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2013-2014

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Vladimir Tolmachev in Cancer Research**

Introduction

Vladimir Tolmachev is a prominent inventor based in Uppsala, Sweden. With two notable patents to his name, he is making significant strides in the field of medical research, particularly focusing on cancer therapies. His work exemplifies the integration of innovative biochemistry and advanced imaging techniques in the fight against cancer characterized by the overexpression of HER2.

Latest Patents

Tolmachev's latest patents reveal groundbreaking advancements in polypeptides designed for HER2 binding. His innovative polypeptides feature a specific amino acid sequence and have the ability to form radiolabeled compounds with radionuclides. These formulations facilitate in vivo imaging and targeting of cancers marked by HER2 overexpression. The patents disclose methodologies that involve administering these radiolabeled polypeptides and utilizing medical imaging tools to obtain diagnostic images. Notably, the patents also encompass nucleic acids encoding these polypeptides and expression vectors, potentially revolutionizing cancer diagnosis and treatment protocols.

Career Highlights

Vladimir Tolmachev is affiliated with Affibody AB, a biotechnology company known for its innovative work in developing targeted therapies and diagnostics. His extensive research and patent contributions have solidified his position as a key figure in translating scientific discoveries into practical applications in oncology.

Collaborations

Throughout his career, Tolmachev has collaborated with esteemed colleagues including Lars Abrahmsén and Nina Herne. These partnerships reflect a collective effort to enhance cancer treatment methodologies and improve patient outcomes through innovative scientific approaches.

Conclusion

Vladimir Tolmachev's contributions to cancer research underscore the importance of innovation in medical science. His patents not only advance the understanding of HER2 binding polypeptides but also open new avenues for the development of diagnostic and therapeutic solutions, showcasing the vital role of inventors in shaping the future of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…